Filing Flows › Comparisons › CAMP vs ALMS
Camp4 Therapeutics vs Alumis: CAMP and ALMS compared
Camp4 Therapeutics is the larger company: $1.9M of revenue in its latest quarter (Q3 2026) against $1.7M for Alumis (Q2 2026). Camp4 Therapeutics is growing faster (+139% against -38% a year earlier).
Where the money goes: CAMP and ALMS
Camp4 Therapeutics (CAMP) · Q3 2026
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart follows the revenue to costs, profit and cash.
Alumis (ALMS) · Q2 2026
Alumis, Q2 2026: revenue $1.7M (-38% year over year), net loss $142M, operating cash flow −$81.5M. The chart follows the revenue to costs, profit and cash.
| Camp4 Therapeutics (CAMP) | Alumis (ALMS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $1.9M | $1.7M |
| Revenue growth, Y/Y | +139% | -38% |
| Operating margin | -738.8% | n/m |
| Net earnings | −$29.0M | −$142M |
| Operating cash flow | −$8.2M | −$81.5M |
Questions
Which is bigger, Camp4 Therapeutics or Alumis?
Camp4 Therapeutics is the larger company: $1.9M of revenue in its latest quarter (Q3 2026) against $1.7M for Alumis (Q2 2026).
Is Camp4 Therapeutics or Alumis growing faster?
Camp4 Therapeutics is growing faster (+139% against -38% a year earlier).
More: Camp4 Therapeutics earnings · how Camp4 Therapeutics makes money · Alumis earnings · how Alumis makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.